about
Clinical characteristics and treatment outcomes of colorectal cancer in renal transplant recipients in Korea.Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients.Adefovir- or Lamivudine-Induced Renal Tubular Dysfunction after Liver Transplantation.Efficacy of rabbit anti-thymocyte globulin for steroid-resistant acute rejection after liver transplantation.Proliferation and functional assessment of pseudo-islets with the use of pancreatic endocrine cells.Illumina-microarray analysis of mycophenolic acid-induced cell death in an insulin-producing cell line and primary rat islet cells: new insights into apoptotic pathways involved.A 6-month, open-label, multicenter clinical study in Korean de novo renal transplant patients evaluating the efficacy, safety, and tolerance of myfortic concomitantly used with tacrolimus.Impact of Pre-Transplant Bacterial Infections on Post-Operative Outcomes in Patients after Liver Transplantation.Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.Adjustment Experience of Kidney Transplantation Recipients in Korea.Manufacturing of insulin-secreting spheroids with the RIN-5F cell line using a shaking culture method.Health-Related Quality of Life and Psychologic Distress in Korean Kidney Transplant Recipients.Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution.Hepatic splenosis preoperatively diagnosed as hepatocellular carcinoma in a patient with chronic hepatitis B: a case report.Risk factors and characteristics of post-transplant tuberculosis in an endemic area.Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?Which patients with intestinal obstruction need surgery? The delta neutrophil index as an early predictive marker.Early Weight Gain After Transplantation Can Cause Adverse Effect on Transplant Kidney Function.Clinical significance of lactate clearance for the development of early allograft dysfunction and short-term prognosis in deceased donor liver transplantation.Does video-assisted minilaparotomy surgical living donor nephrectomy satisfy donors?Analysis of transplant outcomes after five or six human leukocyte antigen-mismatched living donor kidney transplantation.Exchange living-donor kidney transplantation: merits and limitations.Mycophenolic acid inhibits oleic acid-induced vascular smooth muscle cell activation by inhibiting cellular reactive oxygen species.Immunologic control for polyomavirus infection after kidney transplantation.Impact of Early Hospital Readmissions After Kidney Transplantation on Graft FunctionFollow-up Status of Living Kidney Donors After TransplantationPretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantationEfficacy of a negative conversion trial and subsequent living donor kidney transplant outcome in recipients with a positive lymphocyte crossmatchUse of the hilar plate looping technique for bile duct dissection in living donor liver transplantation significantly reduces recipient biliary complicationsDoes lymphocyte cross-matching predict acute rejection and graft survival in liver transplantation?Renal transplantation in sensitized recipients with positive luminex and negative CDC (complement-dependent cytotoxicity) crossmatchesA Study on Nursing Students' Knowledge, Attitude, and Educational Needs for Brain-Death Organ Transplantation and Donation and Intent to Donate OrgansDe novo low-dose sirolimus versus mycophenolate mofetil in combination with extended-release tacrolimus in kidney transplant recipients: a multicentre, open-label, randomized, controlled, non-inferiority trialInadequate Sedation Leads to Unexpected Postoperative Wound Evisceration during a Bedside EndoscopyLow-dose mycophenolate mofetil in tablet form or capsule form combined with tacrolimus in the early period after kidney transplantation: a prospective randomized trial
P50
Q35003329-AC00A880-37E8-425F-ADA0-9B2757852E7CQ35076524-1F048E87-A0CC-4CC9-81C2-E74941C54DF1Q36255944-A9ED8D77-CB19-4C6E-A1D9-C558314BDFFFQ37003621-38E8E6B6-9364-46D3-BA9B-A90F58B7CC45Q38314829-00A87039-32E9-40E0-9E6E-48628BA8B366Q38342380-6742F446-26A2-4C52-BB63-B3CA2CC761BCQ38465772-ABCB087B-C8CB-4055-90F8-58839E73AFC1Q39120213-5DE6F75F-4C90-4382-B611-AE7615E05EB0Q39212696-0A1C9299-49A1-4E8C-86B6-717C7D8FE4FAQ39290355-58C10130-F4B1-4C6E-A006-C1DA3E51B46FQ39618435-E6812ECB-9F3F-468B-8F76-11D63A62BDE3Q39730003-3A67F1D4-F494-4628-98DB-ADD339A33532Q41310008-07B1DC30-43B2-46D9-B1BE-6BDABAD831BFQ42186304-219B1CF1-5912-4F38-9D8D-8BE7C16200CCQ45005588-A8D56E6E-C3B2-4ACA-847E-8D5E1EFCCDA2Q46187815-9BA0A2BF-8DE7-4DB9-9B9F-E92652B8248CQ47165793-9059FB0C-6563-4FE3-AFA8-D3C6F74440B0Q47300636-5D86C818-070B-4AE0-9CE5-73F811B3B997Q48185735-1378A9D7-55DE-4863-A968-D6F4279EDB5FQ51362435-52E64CC3-7656-4816-80DE-02739D4B15AAQ53388660-8A308D01-5FAD-42E2-A102-501954D88DE7Q53532888-B145E4C1-B101-4C63-BF3F-59B4BCF1077DQ53562173-C4FB0E84-7239-4BF1-B386-4DE1351D89D2Q54547517-C26E9892-07BC-42C4-8289-D7E934BD02F8Q57489322-0F9B9B3B-D0E6-4CA8-993F-9409EEB790F3Q57489330-CC318148-EC9D-438F-A719-9B84535AAD01Q79468499-DAC4D5D3-7C3C-4679-8268-91B24063A71AQ82818016-CB7F857E-DCF8-41B7-ACFC-BB4F94139969Q82944440-3D7AFA7F-4F9B-4D4F-A17F-BB569F8A486DQ83627778-82E38CCC-439E-4EAA-91B6-AA093B5E393CQ84810649-428A07C7-24C1-4417-8E5E-C7F718B3B5DAQ88581925-C81664CC-8B52-4ACB-AC9A-366B9964758DQ88780752-8CF0FD20-2201-48D3-8F4F-69B36B1F80BBQ91274321-873F0246-B134-40F0-9CD8-7B2F995F813DQ95554843-8F2A790F-655D-432C-BCAA-A6D2A1406D26
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Man Ki Ju
@en
Man Ki Ju
@nl
type
label
Man Ki Ju
@en
Man Ki Ju
@nl
prefLabel
Man Ki Ju
@en
Man Ki Ju
@nl
P31
P496
0000-0002-4112-7003